Crohn's Disease Treatment Practices Lag Behind Latest Research

Despite growing evidence supporting early, aggressive treatment for Crohn's disease, many clinicians continue to favor a traditional, less potent approach. An analysis of recent insurance data revealed that nearly half of newly diagnosed patients began with corticosteroids instead of advanced therapies like biologics. This delay in adopting newer treatment strategies could potentially hinder optimal patient outcomes.